Journal of Medicinal Chemistry · 2013 · 78 citations · 27 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryLead OptimizationHit-to-lead OptimizationLead Compound DesignLead DiscoveryPotency OptimizationStereochemical OptimizationBacterial Cell DivisionBenzimidazole ChemistryLead Compound ScreeningMolecular Target SelectionNovel Antibacterial Drug DiscoveryStructure-based Lead DiscoveryStructure-guided Lead DiscoveryTherapeutic Target Identification
FtsZ, an essential protein for bacterial cell division, is a highly promising therapeutic target, especially for the discovery and development of new-generation anti-TB agents. Following up the identification of two lead 2,5,6-trisubstituted benzimidazoles, 1 and 2, targeting Mtb-FtsZ in our previous study, an extensive SAR study for optimization of these lead compounds was performed through systematic modification of the 5 and 6 positions. This study has successfully led to the discovery of a highly potent advanced lead 5f (MIC = 0.06 μg/mL) and several other compounds with comparable potencies. These advanced lead compounds possess a dimethylamino group at the 6 position. The functional groups at the 5 position exhibit substantial effects on the antibacterial activity as well. In vitro experiments such as the FtsZ polymerization inhibitory assay and TEM analysis of Mtb-FtsZ treated with 5f and others indicate that Mtb-FtsZ is the molecular target for their antibacterial activity.
27
L A Collins, Scott G. Franzblau · Antimicrobial Agents and Chemotherapy · 1997 · 1.6K citations · Full text
Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacology +7
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
David J. Haydon, Neil R. Stokes, Rebecca Ure et al. · Science · 2008 · 443 citations · Full text